Antiviral drugs targeting Epstein-Barr virus could offer new treatment path for multiple sclerosis

Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the…